Dacheng Liu

1.2k total citations
23 papers, 928 citations indexed

About

Dacheng Liu is a scholar working on Pulmonary and Respiratory Medicine, Statistics and Probability and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dacheng Liu has authored 23 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Statistics and Probability and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dacheng Liu's work include Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Respiratory Support and Mechanisms (6 papers) and Statistical Methods in Clinical Trials (5 papers). Dacheng Liu is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Respiratory Support and Mechanisms (6 papers) and Statistical Methods in Clinical Trials (5 papers). Dacheng Liu collaborates with scholars based in United States, Germany and Belgium. Dacheng Liu's co-authors include Hulin Wu, Sanjay Patel, Andrew Lewin, Yangxin Huang, Uli C. Broedl, Renee Kaste, Hans J. Woerle, Ralph A. DeFronzo, Hans J. Woerle and Ralph A. DeFronzo and has published in prestigious journals such as Journal of the American Statistical Association, Diabetes Care and Journal of Virology.

In The Last Decade

Dacheng Liu

21 papers receiving 897 citations

Peers

Countries citing papers authored by Dacheng Liu

Since Specialization

Citations

This map shows the geographic impact of Dacheng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dacheng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dacheng Liu more than expected).

Fields of papers citing papers by Dacheng Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dacheng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dacheng Liu. The network helps show where Dacheng Liu may publish in the future.

Co-authorship network of co-authors of Dacheng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Dacheng Liu. A scholar is included among the top collaborators of Dacheng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dacheng Liu. Dacheng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes 2024 ·UNC Libraries ·Dacheng Liu, Yufeng Liu, (unknown), Haoda Fu	0
2	Multiplicity issues for platform trials with a shared control arm 2020 ·Journal of Biopharmaceutical Statistics ·(unknown), Qiqi Deng, Dacheng Liu	13
3	Machine Learning to Identify Predictors of Glycemic Control in Type 2 Diabetes: An Analysis of Target HbA1c Reduction Using Empagliflozin/Linagliptin Data 2019 ·Pharmaceutical Medicine ·Angelo Del Parigi, Wenbo Tang, Dacheng Liu, Christopher S. Lee, Richard E. Pratley	12
4	Power and Sample Size for Dose-Finding Studies with Survival Endpoints Under Model Uncertainty 2018 ·Biometrics ·Qiqi Deng, (unknown), Dacheng Liu, (unknown), Zhiliang Ying, D. Y. Lin	3
5	Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes 2018 ·Journal of the American Statistical Association ·(unknown), Dacheng Liu, Haoda Fu, Yufeng Liu	31
6	Recruiting Patients After Hospital Discharge for Acute Exacerbation of COPD: Challenges and Lessons Learned 2017 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·Gary T. Ferguson, (unknown), Emmanuelle Clerisme-Beaty, Dacheng Liu, Byron Thomashow, Robert A. Wise, Richard ZuWallack, Barry J. Make	7
7	Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses 2016 ·Respiratory Medicine ·Donald P. Tashkin, Eric Bateman, Paul Jones, Valentina Bayer Zubek, Norbert Metzdorf, Dacheng Liu, Thomas B. Leonard, Emmanuelle Clerisme-Beaty, Robert A. Wise	4
8	Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial 2016 ·Respiratory Research ·Bartolomé R. Celli, Marc Decramer, Dacheng Liu, Norbert Metzdorf, Guus Asijee, Donald P. Tashkin	5
9	Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin 2015 ·Diabetes Care ·Ralph A. DeFronzo, Andrew Lewin, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl	244
10	Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes 2015 ·Diabetes Care ·Andrew Lewin, Ralph A. DeFronzo, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl	160
11	Tiotropium might improve survival in subjects with COPD at high risk of mortality 2014 ·Respiratory Research ·Pierre‐Régis Burgel, (unknown), Daniel Dusser, Nicolás Roche, Dacheng Liu, Yufeng Liu, (unknown), Norbert Metzdorf, Marc Decramer, (unknown)	8
12	Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®) 2013 ·Respiratory Medicine ·Wim Janssens, Yang Liu, Dacheng Liu, Steven Kesten, Donald P. Tashkin, Bartolomé R. Celli, M. Decramer	14
13	Efficacy and Tolerability of Linagliptin Added to a Sulfonylurea Regimen in Patients With Inadequately Controlled Type 2 Diabetes Mellitus: An 18-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial 2012 ·Clinical Therapeutics ·Andrew Lewin, (unknown), Dacheng Liu, Sanjay Patel, Maximilian von Eynatten, Hans‐Juergen Woerle	46
14	Cause-specific mortality adjudication in the UPLIFT® COPD trial: Findings and recommendations 2011 ·Respiratory Medicine ·Lorcan McGarvey, Sheldon Magder, D Burkhart, Steven Kesten, Dacheng Liu, Raymond C. Manuel, D. E. Niewoehner	62
15	Efficacy of tiotropium in COPD patients from Asia: A subgroup analysis from the UPLIFT trial 2011 ·Respirology ·Yoshinosuke Fukuchi, Lenora Fernandez, Han‐Pin Kuo, Aziah Ahmad Mahayiddin, Bartolomé R. Celli, Marc Decramer, Steven Kesten, Dacheng Liu, Donald P. Tashkin	43
16	Adverse health consequences in COPD patients with rapid decline in FEV1 - evidence from the UPLIFT trial 2011 ·Respiratory Research ·Steven Kesten, Bartolomé R. Celli, Marc Decramer, Dacheng Liu, Donald P. Tashkin	26
17	Premature discontinuation during the UPLIFT study 2011 ·Respiratory Medicine ·Marc Decramer, Geert Molenberghs, Dacheng Liu, Bartolomé R. Celli, Steven Kesten, Ted Lystig, Donald P. Tashkin	16
18	Mixed-Effects State-Space Models for Analysis of Longitudinal Dynamic Systems 2010 ·Biometrics ·Dacheng Liu, (unknown), (unknown), Hulin Wu	18
19	A Comparison Of The Classification Of Cause Of Death Between Site Investigators And A Mortality Adjudication Committee In The UPLIFT® Trial 2010 ·Lorcan McGarvey, Sheldon Magder, Dacheng Liu, Steven Kesten, Raymond C. Manuel, Dennis E. Niewoehner	1
20	Hierarchical Bayesian Methods for Estimation of Parameters in a Longitudinal HIV Dynamic System 2005 ·Biometrics ·Yangxin Huang, Dacheng Liu, Hulin Wu	169

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact